Hospice - Determining Terminal Status; Coverage Indications, Limitations, And/Or Medical Necessity
Submitted by Death Dying and... on Nov 19, 2024 - 4:27pm CST
Medicare coverage of hospice depends on a physician’s certification that an individual’s prognosis is a life expectancy of six months or less if the terminal illness runs its normal course. This LCD describes guidelines to be used by National Government Services (NGS) in reviewing hospice claims and by hospice providers to determine eligibility of beneficiaries for hospice benefits. Although guidelines applicable to certain disease categories are included, this LCD is applicable to all hospice patients. It is intended to be used to identify any Medicare beneficiary whose current clinical status and anticipated progression of disease is more likely than not to result in a life expectancy of six months or less.
Indications: A patient will be considered to have a life expectancy of six months or less if he/she meets the non-disease specific "Decline in clinical status" guidelines described in Part I. Alternatively, the baseline non-disease specific guidelines described in Part II plus the applicable disease specific guidelines listed in Part III will establish the necessary expectancy.
Non-disease specific guidelines are included. Indication guidelines fo specific diseases are also listed, including cancer, ALS, demensia due to Alzheimer's, heart disease, HIV, liver disease, pulmonary disease, renal disease, acute renal failure, CKD, stroke and coma, stroke, and heart failure.
About the organization: The Centers for Medicare & Medicaid Services (CMS) is a federal agency that provides health coverage to more than 160 million through Medicare, Medicaid, the Children's Health Insurance Program, and the Health Insurance Marketplace. CMS works in partnership with the entire health care community to improve quality, equity and outcomes in the health care system.
Resource Type: Guideline
Start the Conversation
Every registered user can comment on website content.
Please login or register to comment